• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Immunopurification of human factor VIII/vWF complex from plasma.

作者信息

Mejan O, Fert V, Delezay M, Delaage M, Cheballah R, Bourgois A

机构信息

Immunotech, Marseille, France.

出版信息

Thromb Haemost. 1988 Jun 16;59(3):364-71.

PMID:3142074
Abstract

In this study we describe a process for immunopurification of FVIII/vWF complex directly from plasma. A mAb against vWF has been selected that is able to bind, under physiologic conditions, the FVIII/vWF complex and to release it in slightly alkaline conditions while preserving its activity. After investigating the influence of solid supports and of coupling methods on the recovery of active FVIII we produced an immunoadsorbent by immobilisation of the selected mAb onto a Sephacryl S-1000 support using a benzoquinone coupling method. With this immunoadsorbent we developed a purification process directly from plasma with an excellent recovery (50%) of both FVIII and vWF activities. The product obtained is very enriched (the FVIII:C specific activity is 20 IU/mg of protein) and is stable after lyophilization.

摘要

相似文献

1
Immunopurification of human factor VIII/vWF complex from plasma.
Thromb Haemost. 1988 Jun 16;59(3):364-71.
2
Immunoaffinity purification of factor VIII complex.
Thromb Haemost. 1987 Feb 3;57(1):102-5.
3
Progress in large-scale purification of factor VIII/von Willebrand factor concentrates using ion-exchange chromatography.利用离子交换色谱法大规模纯化凝血因子VIII/血管性血友病因子浓缩物的进展。
Vox Sang. 2008 Nov;95(4):298-307. doi: 10.1111/j.1423-0410.2008.01096.x.
4
Purification of recombinant human B-domain-deleted factor VIII using anti-factor VIII monoclonal antibody selected by the surface plasmon resonance biosensor.使用表面等离子体共振生物传感器筛选的抗凝血因子VIII单克隆抗体纯化重组人B结构域缺失的凝血因子VIII
Biotechnol Prog. 2001 Nov-Dec;17(6):1119-27. doi: 10.1021/bp010100o.
5
The interaction of the factor VIII/von Willebrand factor complex (VIII/vWf), with guanidinium-derivatized matrices.凝血因子VIII/血管性血友病因子复合物(VIII/vWf)与胍盐衍生化基质的相互作用。
Bioseparation. 1991;2(3):177-86.
6
von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.不同纯度的凝血因子 VIII 浓缩物中所含的血管性血友病因子支持来自异质性血管性血友病患者组的血样中的血小板黏附。
Haematologica. 1998 Nov;83(11):1009-14.
7
Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay.通过胶原蛋白结合试验测定治疗性凝血因子VIII浓缩物生产过程中血管性血友病因子的生物活性。
Biologicals. 1998 Jun;26(2):155-66. doi: 10.1006/biol.1998.0127.
8
Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).血浆中凝血因子VIII和血管性血友病因子的标准化:第4个国际标准品(97/586)的校准
Thromb Haemost. 2001 Apr;85(4):634-8.
9
Pharmacokinetics of monoclonally-purified and recombinant factor VIII in patients with severe von Willebrand disease.单克隆纯化及重组因子VIII在重度血管性血友病患者中的药代动力学
Thromb Haemost. 1993 Aug 2;70(2):270-2.
10
Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.鼻内给予去氨加压素导致血浆血管性血友病因子增加,改变了重度甲型血友病患者高纯度凝血因子VIII浓缩物的药代动力学。
Haemophilia. 1999 Mar;5(2):88-95.